FibroBiologics
Business Services · Texas, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
455 E Medical Center Blvd Ste 300, Houst...Phone Number
(281) 671-5150Website
www.fibrobiologics.comRevenue
-Stock Symbol
FBLGIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
2
2
1
1
1
About FibroBiologics
FibroBiologics is a clinical-stage biotechnology company advancing regenerative medicine by developing and commercializing fibroblast cell-based therapies aimed at treating and potentially curing chronic diseases. Its proprietary platform leverages fibroblasts and fibroblast-derived materials to create biologic treatments for conditions such as wound healing, degenerative disorders, autoimmune diseases and tissue regeneration. The company holds a large portfolio of patents and is focused on next-generation cell therapy innovation.Explore more
FibroBiologics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is FibroBiologics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once FibroBiologics has new funding data
Product Launch: Get notified when FibroBiologics launches new products
Check if FibroBiologics has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on FibroBiologics recently announced quarterly report
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at FibroBiologics
FibroBiologics, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if FibroBiologics had a recent Job posting/layoffs
Check out if FibroBiologics is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Find VP level buyers at FibroBiologics
Find more new buyers
Compare Similar Companies to FibroBiologics
Compare insights from companies similar to FibroBiologics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
FibroBiologics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
FibroBiologics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about FibroBiologics.
FibroBiologics financials insights
Gather financial insights about FibroBiologics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Debt
$100M
2023
Other Financing Round
$5M
2025
Other Financing Round
$5M
2026
Stock/Share Issuance
$3M
FibroBiologics Tech Stack
A closer look at the technologies used by FibroBiologics
Most Recent Scoops
Funding
Funding
Pain Point
FibroBiologics is currently in a Nasdaq compliance monitoring period through early next year, as the company's common stock is trading below $1, raising stockholder concerns about the risk of an additional reverse stock split or potential Nasdaq delisting.
Compliance, Stake & Stock Ownership, Finance, Risk
Person-Based
Person-Based
Person-Based
FibroBiologics News & Media
FibroBiologics Raises $3.0 Million in Private Placement; Issues Pre-Funded and Common Warrants
FibroBiologics closed a $3.0 million private placement, issuing pre-funded warrants for up to 4,081,633 shares and short-term and long-term warrants totaling 8,163,266 shares at a $0.735 exercise price, subject to stockholder approval. Net proceeds were about $2.6 million, intended for working capi…FibroBiologics Announces Closing of up to $9.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules
$3.0 million upfront with up to approximately $6.0 million of potential additional gross proceeds upon the exercise in full of warrants HOUSTON, June 29, 2026 /PRNewswire/ -- FibroBiologics, Inc. (NASDAQ: FBLG) ("FibroBiologics" or the "Company"), a clinical-stage biotechnology company...FibroBiologics Announces up to $9.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules
$3.0 million upfront with up to approximately $6.0 million of potential additional gross proceeds upon the exercise in full of warrants HOUSTON, June 26, 2026 /PRNewswire/ -- FibroBiologics, Inc. (NASDAQ: FBLG) ("FibroBiologics" or the "Company"), a clinical-stage biotechnology company...FibroBiologics Receives Notice of Allowance for U.S. Patent Covering Topical Fibroblast Spheroid Therapy for Wound Healing
Allowed claims directly support the Company’s ongoing Phase 1/2 clinical trial of CYWC628 in patients with diabetic foot ulcers Allowed claims directly support the Company’s ongoing Phase 1/2 clinical trial of CYWC628 in patients with diabetic foot ulcers
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding FibroBiologics
Sign Up For FreeTo access detailed company insights
FibroBiologics is a clinical-stage biotechnology company advancing regenerative medicine by developing and commercializing fibroblast cell-based therapies aimed at treating and potentially curing chronic diseases. Its proprietary platform leverages fibroblasts and fibroblast-derived materials to create biologic treatments for conditions such as wou... Read More
